References
- Golub T. R., Slonim D. K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J. P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531–7
- Schena M., Shalon D., Heller R., Chai A., Brown P. O., Davis R. W. Parallel human genome analysis: microarray‐based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996; 93: 10614–19
- Sorlie T., Perou C. M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869–74
- De Bortoli M., Castellino R. C., Lu X. Y., Deyo J., Sturla L. M., Adesina A. M., et al. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer 2006; 6: 223
- MacDonald T. J., Brown K. M., LaFleur B., Peterson K., Lawlor C., Chen Y., et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001; 29: 143–52
- Aas T., Geisler S., Helle H., Borresen‐Dale A. L., Lonning P. E., Akslen L. A. Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin. Oncol Rep 2005; 13: 525–30
- Hvidsten T. R., Komorowski J., Sandvik A. K., Laegreid A. Predicting gene function from gene expressions and ontologies. Pac Symp Biocomput 2001; 299–310
- Hvidsten T. R., Laegreid A., Komorowski J. Learning rule‐based models of biological process from gene expression time profiles using gene ontology. Bioinformatics 2003; 19: 1116–23
- Chen G., Gharib T. G., Huang C. C., Taylor J. M., Misek D. E., Kardia S. L., et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002; 1: 304–13
- Gygi S. P., Rochon Y., Franza B. R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19: 1720–30
- Lichtinghagen R., Musholt P. B., Lein M., Romer A., Rudolph B., Kristiansen G., et al. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 2002; 42: 398–406
- Misund K., Steigedal T. S., Laegreid A., Thommesen L. Inducible cAMP early repressor splice variants ICER I and IIgamma both repress transcription of c‐fos and chromogranin A. J Cell Biochem 2007
- Gornall A. G., Bardawill C. J., David M. M. Determination of serum proteins by means of the Biuret reaction. J Biol Chem 1949; 177: 751–66
- Walker W. H., Sanborn B. M., Habener J. F. An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP‐induced transcription. Proc Natl Acad Sci USA 1994; 91: 12423–7
- Steigedal T. S., Bruland T., Misund K., Thommesen L., Laegreid A. Inducible cAMP early repressor suppresses gastrin‐mediated activation of cyclin D1 and c‐fos gene expression. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1062–9
- Thommesen L., Norsett K., Sandvik A. K., Hofsli E., Laegreid A. Regulation of inducible cAMP early repressor expression by gastrin and cholecystokinin in the pancreatic cell line AR42J. J Biol Chem 2000; 275: 4244–50